Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating on FrancoNevada with Adjusted Price Target

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_Investment (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 11, 2024, analyst Heiko Ihle from HC Wainwright & Co. reiterated a Buy rating on Franco-Nevada (NYSE:FNV) while adjusting the price target down from $185 to $175. This update suggests continued confidence in the stock, with a slightly revised target price that reflects a positive outlook.

Franco-Nevada Corporation (FNV) Stock Price Surges on March 11, 2024: Factors Driving the Positive Performance

On March 11, 2024, Franco-Nevada Corporation (FNV) saw a positive performance in its stock price. The price of FNV shares increased by $2.78 since the market last closed, representing a 2.48% rise from the previous closing price of $115.02. Additionally, in pre-market trading, the stock continued to climb, with a further increase of $2.73. This positive price momentum may be attributed to various factors, such as favorable market conditions, company-specific news, or investor sentiment. Investors may be reacting positively to recent developments or announcements related to Franco-Nevada Corporation, driving up demand for the stock. It is important to note that while short-term price movements can be exciting, investors should also consider the long-term fundamentals of a company before making investment decisions. Conducting thorough research and analysis can help investors make informed choices and mitigate risks associated with investing in the stock market. Overall, FNV’s strong performance on March 11, 2024, highlights the dynamic nature of the stock market and the importance of staying informed and vigilant as an investor. Monitoring price movements, market trends, and company news can help investors navigate the ever-changing landscape of the stock market and make sound investment decisions.

Franco-Nevada Corporation (FNV) Financial Performance Review: Revenue Decline and Stability in Fourth Quarter

On March 11, 2024, Franco-Nevada Corporation (FNV) experienced a mixed performance in terms of its financials. According to data from CNN Money, the company reported a total revenue of $1.22 billion for the past year, which represented a 7.48% decrease compared to the previous year. However, the total revenue remained flat at $303.50 million in the fourth quarter.

In terms of net income, FNV reported a loss of $466.40 million for the past year, which was a significant decrease of 166.57% compared to the previous year. On the other hand, the net income increased slightly by 0.0% to -$982.50 million in the fourth quarter.

Earnings per share (EPS) also showed a similar trend, with a decrease of 166.54% to -$2.43 for the past year and an increase of 0.0% to -$5.11 in the fourth quarter.

Overall, FNV’s financial performance on March 11, 2024, reflected a challenging year with a decrease in total revenue, net income, and EPS compared to the previous year. However, the company managed to hold its revenue and net income flat in the fourth quarter, indicating some stability in its financials.

Tags: FNV
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ Trading ratings today (2)

Barclays Analyst Brandon Oglenski Upgrades XPO Rating to Overweight with New Price Target of 145

Sam Edelmans SpringSummer 2024 Campaign Featuring Kylie Jenner Celebrating 20 Years of Style

Cleanest energy and ev

Uranium Energy Corp Reports Decline in Quarterly Financial Performance

Recommended

EEFT stock news

Analyst Ratings and Price Targets for Definitive Healthcare

2 years ago
Healthcare Services Stock Exchange

Analyst Ratings and Price Targets for Inari Medical NASDAQNARI

2 years ago
STZ stock news

Analyzing Analyst Recommendations and Target Price for FirstEnergy Corp.

2 years ago
Healthcare-sector

Introducing the Revolutionary Herbalife GLP1 Nutrition Companion

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

Is 3M’s Resurgence Signaling a Sustainable Recovery?

Eastman Chemical’s Challenging Quarter: A Deep Dive into the Numbers

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

Trending

MannKind Stock
Analysis

MannKind Shares Surge on Exceptional Quarterly Performance

by Robert Sasse
November 6, 2025
0

MannKind Corporation witnessed a substantial rally in its share price following the release of its third-quarter 2025...

Amgen Stock

Amgen’s Impressive Quarterly Performance Fuels Investor Confidence

November 6, 2025
Teledyne Stock

An Overlooked AI Contender Emerges in Defense Technology

November 6, 2025
Molina Healthcare Stock

Molina Healthcare: Crisis or Opportunity as Legal Storms and a Legendary Investor Collide?

November 6, 2025
Nio Stock

Nio’s Unprecedented Delivery Streak Fuels Profitability Push

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • MannKind Shares Surge on Exceptional Quarterly Performance
  • Amgen’s Impressive Quarterly Performance Fuels Investor Confidence
  • An Overlooked AI Contender Emerges in Defense Technology

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com